Filter News
Area of Research
- (-) National Security (3)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (29)
- Clean Energy (10)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (6)
- Materials (7)
- Materials for Computing (2)
- Neutron Science (13)
- Supercomputing (19)
News Type
News Topics
- (-) Biomedical (4)
- (-) Biotechnology (1)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (12)
- Artificial Intelligence (12)
- Big Data (6)
- Bioenergy (4)
- Biology (5)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (5)
- Computer Science (21)
- Coronavirus (3)
- Cybersecurity (19)
- Decarbonization (3)
- Energy Storage (2)
- Environment (6)
- Exascale Computing (1)
- Frontier (1)
- Fusion (9)
- Grid (6)
- High-Performance Computing (4)
- Isotopes (5)
- Machine Learning (12)
- Materials (2)
- Materials Science (6)
- Molten Salt (4)
- Nanotechnology (1)
- National Security (35)
- Neutron Science (9)
- Nuclear Energy (40)
- Partnerships (5)
- Physics (3)
- Quantum Science (1)
- Security (11)
- Simulation (1)
- Space Exploration (5)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
ORNL scientists had a problem mapping the genomes of bacteria to better understand the origins of their physical traits and improve their function for bioenergy production.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.